DCT has developed what is ostensibly the most sensitive test available for objective, reliable, and quantified measurement of cognitive function. The test was developed over the past 10 yrs at MIT and Lahey Hospital & Medical Center using artificial intelligence technology and clinical expertise with normative data from the Framingham Heart Study to unlock robust measures of brain function from natural drawing behavior. Potential uses are to screen for cognitive impairment, monitor cognitive health over time, and track change in cognitive function in response to treatment. It is non-invasive, inexpensive, takes less than 2 min to perform, provides instant results, and takes up less counter space than a smartphone.
We welcome you to contact us for information regarding research and commercial availability at [email protected].
Company’s Keywords:
<4
<7000000
<2015
Your request has been submitted successfully.
Own or work here?